You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Characteristics of patients with end-stage renal disease and population control at study entry

From: Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study

Variable ESRD individuals (N = 10,908) Population controls (N = 189,850)
Median years of follow-up, (interquartile range) 2.3 (0.8–5.1) 6.4 (2.9–10.5)
Age at entry (N = 200,758)
16-49 2,481 (22.7%) 39,901 (21.0%)
50-64 3,314 (30.4%) 57,471 (30.3%)
65+ 5,113 (46.9%) 92,478 (48.7%)
Sex (N = 200,758)
Female 4,059 (37.2%) 71,664 (37,7%)
Male 6,849 (62.8%) 118,186 (62.3%)
Diabetes (N = 200,758)
No 8,443 (77.4%) 180,475 (95.1%)
Yes 2,465 (22.6%) 9,375 (4.9%)
m-CCI score (N = 200,758)
Low 3,145 (28.8%) 133,599 (70.4%)
Moderate 4,232 (38.8%) 43,923 (23.14%)
High 3,531 (32.4%) 12,328 (6.5%)
SAB event (N = 200,758)
No 9,500 (87.1%) 189,117 (99.6%)
Yes 1,4081 (12.9%) 733 (0.4%)
  1. ESRD: end-stage renal disease; m-CCI: modified Charlson Comorbidity Index; SAB: Staphylococcal aureus bacteremia.
  2. NOTE. Baseline characteristics. Data are no. of individuals, unless otherwise indicated.
  3. 1Distribution of SAB events according to type of renal replacement therapy: renal transplantation = 23 events, hemodialysis = 1,069 events, and peritoneal dialysis = 316 events.